In the US, Prostigmin (neostigmine systemic) is a member of the following drug classes: cholinergic muscle stimulants, miscellaneous genitourinary tract agents and is used to treat Myasthenia Gravis and Urinary Retention.
Ingredient matches for Prostigmin
Neostigmine is reported as an ingredient of Prostigmin in the following countries:
Neostigmine bromide (a derivative of Neostigmine) is reported as an ingredient of Prostigmin in the following countries:
- United States
Neostigmine metilsulfate (a derivative of Neostigmine) is reported as an ingredient of Prostigmin in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.